AbelZeta Announces Abstract for C-CAR031 Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingPRNewsWire • 04/25/24
AstraZeneca, Sanofi Jump On First-Quarter Earnings; Bristol Myers LagsInvestors Business Daily • 04/25/24
Britain's Magnificent 7: Do Rolls-Royce, AstraZeneca and Unilever make the cut?Proactive Investors • 04/24/24
Big pharma is looking to fatten profits with buyouts of weight-loss drug companies. Here are 4 candidates.Market Watch • 04/16/24
Asher Bio Closes $55 Million Series C Financing to Advance Lead Program into Phase 1b Clinical TrialsBusiness Wire • 04/16/24
IMFINZI® (durvalumab) plus chemotherapy doubled overall survival rate at three years for patients with advanced biliary tract cancer in TOPAZ-1 Phase III trialBusiness Wire • 04/16/24